Trial Profile
Pharmacogenomic Study for Individual Response to CPT-11 in Colorectal Cancer Patients (Step 2)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2013
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Pharmacogenomic; Therapeutic Use
- 03 Jun 2009 New trial record.